期刊文献+

p53和c-myc异常表达与膀胱癌多药耐药性 被引量:2

CORRELATION BETWEEN THE ABNORMAL EXPRESSION OF p53 AND c myc WITH MULTIDRUG RESISTANCE IN BLADDER CANCER
原文传递
导出
摘要 为探讨p53和c-myc基因异常表达与膀胱癌多药耐药性(MDR)的关系,应用ABC免疫组织化学方法检测67例膀胱癌癌细胞中p53和c-myc的表达产物及多药耐药基因(mdr-1)产物P-gp。结果显示p53突变蛋白蓄积的膀胱癌中P-gp阳性表达率92.3%;p53阴性者P-gp阳性率为36.6%。P-gp表达与p53突变蛋白蓄积呈显著正相关(r=0.64,P<0.05);而c-myc和mdr-1的表达无明显相关。提示:p53异常表达可增加mdr-1基因的表达。 In order to study the correlation between abnormal expression of p53 and c myc with multidrug resistance (MDR) in bladder cancer,and by using ABC immunohistochemical methods, the expression products of p53 and c myc and P gp/mdr 1 in 67 cases of bladder cancer was tested. The P gp positive rate of p53 protein accumulation in bladder cancer was 92.3%, while P gp positive rate of p53 negitive was 36.6%. A significant correlation was found between p53 protein accumulation and mdr 1 gene expression ( r =0.64, P <0.05),while there was no correlation between c myc and mdr 1. p53 protein accumulation might increase the expression of mdr 1 gene, and the bladder cancer cell can get MDR phenotype.
出处 《肿瘤研究与临床》 CAS 1998年第3期145-147,共3页 Cancer Research and Clinic
关键词 膀胱肿瘤 P53基因 C-MYC基因 异常表达 多药耐药 Bladder cancer p53 protein c myc P gp Multidrug resistance
  • 相关文献

参考文献2

二级参考文献9

  • 1周兴,中华泌尿外科杂志,1992年,13卷,272页
  • 2吴长利,中华泌尿外科杂志,1996年,17卷
  • 3张广健,中华泌尿外科杂志,1996年,17卷
  • 4韩瑞发,中华泌尿外科杂志,1994年,15卷,419页
  • 5葛成华,国外医学肿瘤学分册,1993年,20卷,132页
  • 6关中宏,中华泌尿外科杂志,1993年,14卷,248页
  • 7周中军,国外医学肿瘤学分册,1992年,19卷,1页
  • 8赵跃然,国外医学肿瘤学分册,1991年,18卷,216页
  • 9Chan H S L,J Clin Oncol,1990年,8卷,689页

共引文献4

同被引文献21

  • 1韩瑞发,朱方立,马腾骧,王瑞林,张淑敏.前列腺癌MDR-PGP170与突变P53表达[J].中华泌尿外科杂志,1996,17(5):298-301. 被引量:9
  • 2张志华,高振强,张秀珑,李桂林,张春山,刘昭.多向药物耐性和多向耐药相关基因及其产物在人肺癌中共同表达的研究[J].中华内科杂志,1997,36(2):123-124. 被引量:6
  • 3Van Brussel JP, Jan Van Steenbrugge G, Van Krimpen C, et al. Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer[J].J Urol,2001,165(1):130-135.
  • 4Nakanishi Y, Kawasaki M, Bai F, et al. Expression of p53 and glutathione Stransferase-pi relates to clinical drug resistance in non-small cell lung cancer[J]. Oncology,1999, 57(4):318-323.
  • 5曾进.现代泌尿肿瘤学[M].武汉:湖北科学技术出版社,1997.264-266.
  • 6Cole SPC,Bhardwaj G,Gerlach JH,et al. Overexpression of a transporter gene in muhidrug-resistant human lung cancer cell line. Scince, 1992,258 : 1650.
  • 7Linn SC, Pinedo HM, van-Ark Otte J, et al. Expression of drug resistance proteins in breast cancer, in relation to chemotherapy. Int J Cancer,1997,71:787.
  • 8Lonn U, Lonn S, Nylen U,et al. Appearence and detection of multiple copies of the mdr-1 gene in clinical samples of mammary carcinoma. Int J Cancer, 1992,51 : 682.
  • 9Hennequin E ,Delvincourt C,Pourny C,et al. Expression of mdr-1 gene in human breast primary tumors and metastases. Breast Cancer Res Treat,1993,26:267.
  • 10Goldstein LJ,Galski H,Tojo A,et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst,1989,81:116.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部